合成路线1
该中间体在本合成路线中的序号:
(II) This compound can be prepared in several different ways:
1) By reaction of p-chlorobenzoyl chloride (I) with N-(2-aminoethyl)morpholine (II) in pyridine.
2) By reaction of p-chlorobenzoyl anhydride (III) with N-(2-aminoethyl)morpholine (II) in pyridine.
3) By reaction of methyl p-chlorobenzoate (IV) with N-(2-aminoethyl)morpholine (II) at 120 C.
4) By reaction of N-(p-chlorobenzoyl)succinimide (V) with N-(2-aminoethyl)morpholine (II) in dioxane.
5) By reaction of p-nitrophenyl p-chlorobenzoate (VI) with N-(2-aminoethyl)morpholine (II) in THF.
6) By reaction of p-chloro-N-(2-chloroethyl)benzamide (VII) with morpholine (VIII) at 100 C.
7) By reaction of p-chlorobenzoylaziridine (IX) with morpholine (VIII) in refluxing toluene.
8) By reaction of p-chlorobenzaldehyde (X) with N-(2-aminoethyl)morpholine (II) in refluxing benzene to give 4-[2-[(p-chlorobenzylidene)amino]ethyl]morpholine (XI), followed by an oxidation with H2O2 in methanol.
9) By reaction of p-chloro-N-(2-morpholinoethyl)thiobenzamide (XII) with lead tetraacetate in refluxing water.
11) By reaction of p-chlorobenzoic acid (XIV) with N-(2-aminoethyl)morpholine (II) by means of dicyclohexylcarbodiimide in pyridine, or by means of chloroformic acid ethyl ester and triethylamine in acetone.
10) By isomerization of (alpha-(p-chlorophenyl)-N-(2-morpholinoethyl)nitrone (XIII) in hot acetic acid - acetic anhydride, followed by a treatment with NaOH.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10295 |
p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride
|
122-01-0 |
C7H4Cl2O |
详情 | 详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(III) |
30702 |
4-chloro-1-benzenecarboxylic anhydride
|
|
C14H8Cl2O3 |
详情 |
详情
|
(IV) |
30703 |
methyl 4-chlorobenzoate
|
1126-46-1 |
C8H7ClO2 |
详情 | 详情
|
(V) |
30704 |
1-(4-chlorobenzoyl)-2,5-pyrrolidinedione
|
|
C11H8ClNO3 |
详情 |
详情
|
(VI) |
30705 |
4-nitrophenyl 4-chlorobenzoate
|
|
C13H8ClNO4 |
详情 |
详情
|
(VII) |
30706 |
4-chloro-N-(2-chloroethyl)benzamide
|
|
C9H9Cl2NO |
详情 |
详情
|
(VIII) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(IX) |
30707 |
1-aziridinyl(4-chlorophenyl)methanone
|
|
C9H8ClNO |
详情 |
详情
|
(X) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(XI) |
30708 |
N-[(E)-(4-chlorophenyl)methylidene]-2-(4-morpholinyl)-1-ethanamine; N-[(E)-(4-chlorophenyl)methylidene]-N-[2-(4-morpholinyl)ethyl]amine
|
|
C13H17ClN2O |
详情 |
详情
|
(XII) |
30709 |
4-chloro-N-[2-(4-morpholinyl)ethyl]benzenecarbothioamide
|
|
C13H17ClN2OS |
详情 |
详情
|
(XIII) |
30710 |
[(Z)-(4-chlorophenyl)methylidene][2-(4-morpholinyl)ethyl]ammoniumolate
|
|
C13H17ClN2O2 |
详情 |
详情
|
(XIV) |
18359 |
p-chlorobenzoic acid; 4-chlorobenzoic acid
|
74-11-3 |
C7H5ClO2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By condensation of 3-chloro-4-methyl-6-phenylpyridazine (I) with N-(2-aminoethyl)morpholine (II) by means of powdered Cu in refluxing n-butanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33911 |
3-chloro-4-methyl-6-phenylpyridazine
|
|
C11H9ClN2 |
详情 |
详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The reaction of 3-chloro-4-cyano-6-phenylpyridazine (I) with (4-morpholino)ethylamine (II) in refluxing n-butanol gives title compound.
【1】
Eastland, G. Jr.; SR-95191. Drugs Fut 1987, 12, 2, 137.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22969 |
3-chloro-6-phenyl-4-pyridazinecarbonitrile
|
|
C11H6ClN3 |
详情 |
详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(XVII) The starting product (II) is obtained as follows:
The condensation of N-(tert-butoxycarbonyl)-L-phenylalanine (XI) with magnesium diethylmalonate (XII) by means of N,N'-carbonyldiimidazole in THF - DMSO gives 4(S)-(tert-butoxycarbonylamino)-3-oxo-4-phenylpentanoic acid ethyl ester (XIII), which by an asymetric hydrogenation with H2 and (R)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl-Ruthenium complex in ethanol is converted into 4(S)-(tert-butoxycarbonylamino)-4(S)-hydroxy-5-phenylpentanoic acid ethyl ester (XIV). The hydrolysis of (XIV) with KOH in water - dioxane gives the corresponding free acid (XV), which is hydrogenated with H2 over Rh/Al2O3 in ethanol to yield N-(tert-butoxycarbonyl)cyclostatine (XVI).The condensation of (XVI) with 2-morpholinoethylamine (XVII) by means of triethylamine and diethylphosphoryl cyanide in THF affords the corresponding amide (XVIII), which is finally condensed with N-(tert-butoxycarbonyl)-3-(4-thiazolyl)-L-alanine (XIX) by means of a previous hydrolysis with HCl, followed by the condensation step with diethylphosphoryl cyanide in THF, to give the cyclostatine derivative (II).
【1】
Nishi, T.; Nagahori, H.; Saito, F.; et al.; Syntheses and biological activities of renin inhibitors containing statine analogues. Chem Pharm Bull 1990, 38, 1, 103-9.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(II) |
12865 |
tert-butyl (1S)-2-[((1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-4-[[2-(4-morpholinyl)ethyl]amino]-4-oxobutyl)amino]-2-oxo-1-(1,3-thiazol-4-ylmethyl)ethylcarbamate
|
|
C28H47N5O6S |
详情 |
详情
|
(XI) |
12874 |
(2R)-2-[(tert-Butoxycarbonyl)amino]-3-phenylpropionic acid; N-alpha-t-BOC-L-Phenylalanine |
13734-34-4 |
C14H19NO4 |
详情 | 详情
|
(XII) |
12875 |
Bromo[2-ethoxy-1-(ethoxycarbonyl)-2-oxoethyl]magnesium
|
|
C7H11BrMgO4 |
详情 |
详情
|
(XIII) |
12876 |
ethyl (4S)-4-[(tert-butoxycarbonyl)amino]-3-oxo-5-phenylpentanoate
|
|
C18H25NO5 |
详情 |
详情
|
(XIV) |
12877 |
ethyl (3S,4S)-4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-phenylpentanoate
|
|
C18H27NO5 |
详情 |
详情
|
(XV) |
12878 |
(3S,4S)-4-[(tert-Butoxycarbonyl)amino]-3-hydroxy-5-phenylpentanoic acid
|
72155-46-5 |
C16H23NO5 |
详情 | 详情
|
(XVI) |
12879 |
(3S,4S)-4-[(tert-Butoxycarbonyl)amino]-5-cyclohexyl-3-hydroxypentanoic acid
|
|
C16H29NO5 |
详情 |
详情
|
(XVII) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(XVIII) |
12881 |
tert-butyl (1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-4-[[2-(4-morpholinyl)ethyl]amino]-4-oxobutylcarbamate
|
|
C22H41N3O5 |
详情 |
详情
|
(XIX) |
12882 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(1,3-thiazol-4-yl)propionic acid
|
|
C11H16N2O4S |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) The condensation of N-tert-butoxycarbonyl-cyclostatin (I) with 2-morpholinoethylamine (II) by means of diethyl cyanophosphonate in THF gives the corresponding amide (III), which is deprotected with HCl in dioxane yielding cyclostatin 2-morpholinoethylamide (IV). The condensation of (IV) with N-tert-butoxycarbonyl-3-(4-thiazolyl)-L-alanine (V) by means of diethyl cyanophosphonate as before affords the protected dipeptide (VI), which is treated with HCl in dioxane to obtain the free dipeptide 3-(4-thiazolyl)-L-alanyl-cyclostatin 2-morpholinoethylamide (VII). Finally, this compound is condensed with 3-(morpholinocarbonyl)-2(R)-(4-thiazolyl)propionic acid (VIII) by means of diethyl cyanophosphonate as before.
【1】
Kataoko, M.; Yabe, Y.; Iijima, Y.; Takahagi, H.; Koike, H.; Kokubu, T.; Hiwada, K.; Morisawa, Y. (Sankyo Co., Ltd.); New renin-inhibitory oligopeptides, their preparation and their use. EP 0274259; JP 1989063559; US 5378690 .
|
【2】
Prous, J.; Castaner, J.; ES-6864. Drugs Fut 1989, 14, 9, 852.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
21275 |
4-[(tert-butoxycarbonyl)amino]-5-cyclohexyl-3-hydroxypentanoic acid
|
|
C16H29NO5 |
详情 |
详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(III) |
21277 |
tert-butyl 1-(cyclohexylmethyl)-2-hydroxy-4-[[2-(4-morpholinyl)ethyl]amino]-4-oxobutylcarbamate
|
|
C22H41N3O5 |
详情 |
详情
|
(IV) |
21278 |
4-amino-5-cyclohexyl-3-hydroxy-N-[2-(4-morpholinyl)ethyl]pentanamide
|
|
C17H33N3O3 |
详情 |
详情
|
(V) |
12882 |
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(1,3-thiazol-4-yl)propionic acid
|
|
C11H16N2O4S |
详情 |
详情
|
(VI) |
12865 |
tert-butyl (1S)-2-[((1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-4-[[2-(4-morpholinyl)ethyl]amino]-4-oxobutyl)amino]-2-oxo-1-(1,3-thiazol-4-ylmethyl)ethylcarbamate
|
|
C28H47N5O6S |
详情 |
详情
|
(VII) |
21281 |
4-[[(2S)-2-amino-3-(1,3-thiazol-4-yl)propanoyl]amino]-5-cyclohexyl-3-hydroxy-N-[2-(4-morpholinyl)ethyl]pentanamide
|
|
C23H39N5O4S |
详情 |
详情
|
(VIII) |
12864 |
(2R)-4-(4-Morpholinyl)-2-(1-naphthylmethyl)-4-oxobutyric acid
|
|
C19H21NO4 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The title compound was prepared by condensation of 5-chloro-2-(methylsulfanyl)-8,9-dihydro-7H-thiopyrano[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidine (I) with N-(2-aminoethyl)morpholine (II) in the presence of Et3N in refluxing isopropanol.
【1】
Reiter, J.; Berecz, G.; Zsila, G.; Petocz, L.; Gigler, G.; Fekete, M.; Szecsey, M.; Szirt, E.; Rohacs, L.; Gorgenyl, F.; Csorgo, M. (Egis Pharmaceuticals Ltd.); 1,2,4-Triazolo[1,5-a]pyrimidine derivs.. EP 0500136; GB 2254611; JP 1993148267 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37349 |
5-chloro-8,9-dihydro-7H-thiopyrano[3,2-d][1,2,4]triazolo[1,5-a]pyrimidin-2-yl methyl sulfide; 5-chloro-2-(methylsulfanyl)-8,9-dihydro-7H-thiopyrano[3,2-d][1,2,4]triazolo[1,5-a]pyrimidine
|
|
C9H9ClN4S2 |
详情 |
详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The condensation of 6,7-dichloroquinoline-5,8-dione (I) with 4-(2-aminoethyl)morpholine (II) provided a 2:1 mixture of the title 7-amino quinoline and its 6-amino regioisomer (III), which were separated by column chromatography.
【1】
Cooley, K.A.; Southwick, E.C.; Ducruet, A.P.; Joo, B.; Vogt, A.; Wipf, P.; Aslan, D.C.; Lazo, J.S.; Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J Med Chem 2001, 44, 24, 4042. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53106 |
6,7-dichloro-5,8-quinolinedione
|
n/a |
C9H3Cl2NO2 |
详情 | 详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(III) |
53108 |
7-chloro-6-{[2-(4-morpholinyl)ethyl]amino}-5,8-quinolinedione
|
n/a |
C15H16ClN3O3 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The condensation of 6,7-dichloroquinoline-5,8-dione (I) with 4-(2-aminoethyl)morpholine (II) provided a 1:2 mixture of the title 6-amino quinoline and its 7-amino regioisomer (III), which were separated by column chromatography.
【1】
Cooley, K.A.; Southwick, E.C.; Ducruet, A.P.; Joo, B.; Vogt, A.; Wipf, P.; Aslan, D.C.; Lazo, J.S.; Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J Med Chem 2001, 44, 24, 4042. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
53106 |
6,7-dichloro-5,8-quinolinedione
|
n/a |
C9H3Cl2NO2 |
详情 | 详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(III) |
53107 |
6-chloro-7-{[2-(4-morpholinyl)ethyl]amino}-5,8-quinolinedione
|
n/a |
C15H16ClN3O3 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(III) By cyclization of ethyl acetoacetate (I) with 2-trifluoromethylbenzaldehyde (II) and N-(2-aminoethyl)morpholine (III) in refluxing ethanol
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(II) |
30332 |
2-(trifluoromethyl)benzaldehyde
|
447-61-0 |
C8H5F3O |
详情 | 详情
|
(III) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(XI) Vilsmeier formylation of ethyl 4-methylpyrrole-2-carboxylate (VIII) affords aldehyde (IX). The ethyl ester group of (IX) is subsequently hydrolyzed under alkaline conditions to provide acid (X). Coupling of (X) with 4-(2-aminoethyl)morpholine (XI) gives amide (XII). Then, condensation between aldehyde (XII) and lactam (VII) in the presence of piperidine leads to adduct (XIII). The 4-chloro group of (XIII) is finally displaced with 3-chloro-4-fluoroaniline (XIV) in hot NMP to provide the title compound
【1】
Wei, C.C.; Tang, P.C.; McMahon, G.; Sun, L.; Hirth, K.P.; Liang, C.; Cui, J. (Sugen, Inc.); 4-Substd. 7-aza-indolin-2-ones and their use as protein kinase inhibitors. EP 1244672; WO 0146196 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
60048 |
4-chloro-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one
|
|
C6H4ClN3O |
详情 |
详情
|
(VIII) |
60049 |
ethyl 4-methyl-1H-pyrrole-2-carboxylate
|
|
C8H11NO2 |
详情 |
详情
|
(IX) |
60050 |
ethyl 5-formyl-4-methyl-1H-pyrrole-2-carboxylate
|
|
C9H11NO3 |
详情 |
详情
|
(X) |
60051 |
5-formyl-4-methyl-1H-pyrrole-2-carboxylic acid
|
|
C7H7NO3 |
详情 |
详情
|
(XI) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(XII) |
59999 |
5-formyl-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide
|
|
C13H19N3O3 |
详情 |
详情
|
(XIII) |
59998 |
5-[(4-chloro-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-ylidene)methyl]-4-methyl-N-[2-(4-morpholinyl)ethyl]-1H-pyrrole-2-carboxamide
|
|
C19H21ClN6O3 |
详情 |
详情
|
(XIV) |
18688 |
3-Chloro-4-fluorophenylamine; 3-Chloro-4-fluoroaniline
|
367-21-5 |
C6H5ClFN |
详情 | 详情
|